These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21812534)

  • 1. Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge.
    Montes-Moreno S; Montalbán C; Piris MA
    Leuk Lymphoma; 2012 Feb; 53(2):185-94. PubMed ID: 21812534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
    Colomo L; Loong F; Rives S; Pittaluga S; Martínez A; López-Guillermo A; Ojanguren J; Romagosa V; Jaffe ES; Campo E
    Am J Surg Pathol; 2004 Jun; 28(6):736-47. PubMed ID: 15166665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.
    Montes-Moreno S; Gonzalez-Medina AR; Rodriguez-Pinilla SM; Maestre L; Sanchez-Verde L; Roncador G; Mollejo M; García JF; Menarguez J; Montalbán C; Ruiz-Marcellan MC; Conde E; Piris MA
    Haematologica; 2010 Aug; 95(8):1342-9. PubMed ID: 20418245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse large B-cell lymphomas with plasmablastic differentiation.
    Teruya-Feldstein J
    Curr Oncol Rep; 2005 Sep; 7(5):357-63. PubMed ID: 16091196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.
    Valera A; Colomo L; Martínez A; de Jong D; Balagué O; Matheu G; Martínez M; Taddesse-Heath L; Jaffe ES; Bacchi CE; Campo E
    Mod Pathol; 2013 Oct; 26(10):1329-37. PubMed ID: 23599149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.
    Hu M; Trevino J; Yang L; Cao D; Liu X; Lai J
    In Vivo; 2018; 32(2):413-417. PubMed ID: 29475930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases.
    Li J; Zhao S; Wang J; Chen J; Wen W; Zhang Q
    Tumour Biol; 2016 Mar; 37(3):3619-37. PubMed ID: 26459310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.
    Castillo JJ; Chavez JC; Hernandez-Ilizaliturri FJ; Montes-Moreno S
    Expert Rev Hematol; 2015 Jun; 8(3):343-54. PubMed ID: 25641215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.
    AbdullGaffar B; Seliem RM
    Int J Surg Pathol; 2018 May; 26(3):266-270. PubMed ID: 28982264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
    Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
    Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLI-1 is expressed in a wide variety of hematolymphoid neoplasms: a special concern in the differential diagnosis.
    Cho U; Cha HJ; Kim HJ; Min SK; Kim HK; Jung HR; Park G; Kim JE
    Clin Exp Med; 2024 Jan; 24(1):18. PubMed ID: 38280044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoid Neoplasms With Plasmablastic Differentiation: A Comprehensive Review and Diagnostic Approaches.
    Chen BJ; Chuang SS
    Adv Anat Pathol; 2020 Mar; 27(2):61-74. PubMed ID: 31725418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmablastic lymphoma and related disorders.
    Hsi ED; Lorsbach RB; Fend F; Dogan A
    Am J Clin Pathol; 2011 Aug; 136(2):183-94. PubMed ID: 21757592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD31 expression in plasmacytic/plasmablastic lesions.
    Plocharczyk E; Wakely PE
    Ann Diagn Pathol; 2013 Dec; 17(6):498-501. PubMed ID: 24074836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma.
    Garcia JF; Roncador G; García JF; Sánz AI; Maestre L; Lucas E; Montes-Moreno S; Fernandez Victoria R; Martinez-Torrecuadrara JL; Marafioti T; Mason DY; Piris MA
    Haematologica; 2006 Apr; 91(4):467-74. PubMed ID: 16585013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD117 expression in diffuse large B-cell lymphomas: fact or fiction?
    Vakiani E; Cattoretti G; Colovai AI; Murty VV; Alobeid B; Bhagat G
    Pathol Int; 2005 Nov; 55(11):716-23. PubMed ID: 16271084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
    Simonitsch-Klupp I; Hauser I; Ott G; Drach J; Ackermann J; Kaufmann J; Weltermann A; Greinix HT; Skrabs C; Dittrich C; Lutz D; Pötter R; Mannhalter C; Lechner K; Chott A; Jaeger U
    Leukemia; 2004 Jan; 18(1):146-55. PubMed ID: 14603341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmablastic lymphoma: current perspectives.
    Lopez A; Abrisqueta P
    Blood Lymphat Cancer; 2018; 8():63-70. PubMed ID: 31360094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.
    Guedez L; Martinez A; Zhao S; Vivero A; Pittaluga S; Stetler-Stevenson M; Raffeld M; Stetler-Stevenson WG
    Blood; 2005 Feb; 105(4):1660-8. PubMed ID: 15479729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.